Meta-Analysis
Copyright ©The Author(s) 2024.
World J Orthop. Aug 18, 2024; 15(8): 796-806
Published online Aug 18, 2024. doi: 10.5312/wjo.v15.i8.796
Table 1 The general characteristics of the included studies
Ref.
Study type
Center
Study period
Follow-up in mo
Number of patients
Average age in yr
Sex as male/female
Fracture type and n
Conclusion
PFN
DCS
PFN
DCS
PFN
DCS
Şensöz et al[18], 2023Retrospective cohortDr. Lutfi Kirdar Kartal City Hospital, Istanbul, TurkyBetween 2013 and 2018At least 2 yr362565.5259.3615/2113/12A2.3 61DCS was superior to PFN in early fracture union time. However, it showed a higher nonunion rate. PFN showed shorter hospital stay time than DCS and is recommended to be applied in that fracture type
Jamil et al[14], 2022RCTJawaharlal Nehru Medical College and Hospital, Aligarh Muslim University, Aligarh, IndiaBetween November 2019 to December 2021NA151154.2059.824/116/5A2.2 16/A2.3 10PFN showed better results than DCS regarding operative time, union rate, duration for fracture union, and rate of complications
Ghilzai et al[15], 2016RCTLiaquat National Hospital, Karachi, PakistanFebruary 2012 to August 2013NA211980.0077.00NANAA2.2 21/A2.3 19PFN is superior to DCS in the treatment of proximal femur fractures type 31A3
Sahin et al[19], 2014Retrospective cohortIzmir Tepecik Education and Research Hospital, Izmir, TürkiyeBetween January 2007 and December 2010At least 1 yr423751.7557.5017/2518/19A2.2 44/A2.3 35PFN is superior to DCS in the treatment of unstable peritrochanteric fractures, owing to its effect in reducing operative blood loss, and biological fixation achievement
Elis et al[20], 2012Retrospective cohortTel Aviv Sourasky Medical Center, Tel Aviv, IsraelBetween January 2006 and July 2009At least 1 yr191451.7557.503/163/11A2.2 19/A2.3 14EPFN was as effective as DCS devices for the treatment of reverse oblique hip fractures
Sadowski et al[16], 2002RCTUniversity Hospital of Geneva, Geneva, SwitzerlandBetween March 1998 and June 1999At least 1 yr201988.0077.007/134/14A2.2 20/A2.3 19The results support the use of PFN rather than DCS for the treatment of reverse oblique and transverse intertrochanteric fractures